NANOme
Benchtop system for personalised therapies
NANOme is a benchtop system developed to improve the manufacturing of cell and gene therapies, delivering personalised medicine to patients, one at a time. The plug and play manufacturing system is as easy to use as a capsule-based coffee machine, featuring high efficiency and pharmaceutical product safety. The novel back-to-back system reduces waiting time in-between batches to around 5 minutes, compared to days or weeks. NANOme transforms the production of personalised medicine, enabling wider access to patients for individual patient-specific treatments for life-threatening conditions, e.g. cancer, rare diseases or autoimmune diseases.
Date of Launch
2024
Development Time
more than 24 Month
Target Regions
Europe, North America, South America
Target Groups
Trade / Industry